Cosmos Health Inc. (COSM)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NASDAQ
Market Cap: $12.53M
Last updated: Nov 17, 2026 at 4:34 PM ET
Cosmos Health Inc. (COSM) Stock Chart
Cosmos Health (COSM) has a latest price of $2.85 on Nov 17, 2026, 80.2% below its 52-week high of $14.37. Its price fell 80.3% over the past 12 months. The month-end price fell 98.1% over the 10 years through Oct 2026, a compound annual decline of 32.6%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $114,000.00 in Jan 2018 and its lowest $73.88 in Jun 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart COSM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for COSM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 26.2%, and over 6 months it fell 49.6%. The month-end price fell 70.1% over the 3 years through Oct 2026, a compound annual decline of 33.1%.
| Period | Change |
|---|---|
| 1 month | -56.2% |
| 3 months | -26.2% |
| 6 months | -49.6% |
| 12 months | -80.3% |
| 12 months, with dividends | -80.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -70.1% | -33.1% |
| 5 years | -99.7% | -68.7% |
| 10 years | -98.1% | -32.6% |
Price by Year
Its best calendar year was 2017, when the price rose 1,143.9%, and its weakest was 2022, when it fell 94.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $123.16 | -38.2% |
| 2025 | $199.20 | -25.6% |
| 2024 | $267.60 | -52.6% |
| 2023 | $564.00 | -69.1% |
| 2022 | $1,824.00 | -94.6% |
| 2021 | $33,700.00 | -33.9% |
| 2020 | $51,000.00 | +131.8% |
| 2019 | $22,000.00 | -45.0% |
| 2018 | $40,000.00 | -60.8% |
| 2017 | $102,000.00 | +1,143.9% |
Trading Range
The price is 52.7% below its 50-day average of $6.02 and 51.8% below its 200-day average of $5.91.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.85 | |
| 52-week high | $14.37 | -80.2% |
| 52-week low | $2.46 | +15.9% |
| 50-day average | $6.02 | -52.7% |
| 200-day average | $5.91 | -51.8% |
Price Risk
Over 3 years, its largest fall from a peak was 91.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.71 |
| Largest fall, 1 year | -82.2% |
| Largest fall, 3 years | -91.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About COSM
What is COSM's 1-year price change?
Cosmos Health's price fell 80.3% over the past 12 months. With dividends included, the 12-month total return was -80.3%.
What is COSM's 5-year price change?
Cosmos Health's month-end price fell 99.7% over the 5 years through Oct 2026, a compound annual decline of 68.7%. These figures leave out dividends.
What is COSM's 52-week high and low?
Cosmos Health's 52-week high is $14.37 and its 52-week low is $2.46. Its latest price of $2.85 on Nov 17, 2026 is 80.2% below the high.
What is COSM's beta?
Cosmos Health's 1-year beta against the S&P 500 is 1.71, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 82.2%.
Is the COSM chart free?
Yes. Advanced Charting for COSM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
COSM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors